We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
-$692M
Cap. Flow %
-0.42%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.05%
2 Technology 7.69%
3 Financials 6.83%
4 Healthcare 6.42%
5 Industrials 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
2251
Amgen
AMGN
$236B
$8.43M 0.01%
39,660
-41,262
-51% -$9.5M
BTMD icon
2252
Biote Corp
BTMD
$46.7M
$8.42M 0.01%
865,237
+457,948
+112% +$4.44M
BHVN
2253
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8.41M 0.01%
60,579
+57,379
+1,793% +$7.16M
MCK icon
2254
PUT
McKesson
MCK
$104B
$8.41M 0.01%
+42,200
New +$8.44M
ENDP
2255
DELISTED
Endo International plc
ENDP
$8.41M 0.01%
2,594,893
+1,271,045
+96% +$4.49M
HIII
2256
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
$8.4M 0.01%
863,804
+172,389
+25% +$1.68M
PDOT
2257
DELISTED
Peridot Acquisition Corp. II
PDOT
$8.39M 0.01%
864,169
+35,300
+4% +$342K
FTCH
2258
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$8.39M 0.01%
223,800
-20,200
-8% -$895K
MEKA
2259
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$8.39M 0.01%
+758,961
New +$8.42M
VNQ icon
2260
Vanguard Real Estate ETF
VNQ
$38.8B
$8.38M 0.01%
82,306
-25,470
-24% -$2.7M
NICE icon
2261
Nice
NICE
$6.16B
$8.38M 0.01%
29,485
-60,287
-67% -$16.7M
DXCM icon
2262
DexCom
DXCM
$33.7B
$8.37M 0.01%
+61,244
New +$7.72M
TWNKW
2263
CALL
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$8.37M 0.01%
2,809,848
+852,848
+44% +$2.06M
THCPU
2264
DELISTED
Thunder Bridge Capital Partners IV, Inc. Unit
THCPU
$8.36M 0.01%
848,692
VLTA
2265
DELISTED
Volta Inc.
VLTA
$8.34M 0.01%
964,100
-678,645
-41% -$6.96M
COOK icon
2266
Traeger
COOK
$156M
$8.34M 0.01%
+7,967
New +$9.94M
PTOC
2267
DELISTED
Pine Technology Acquisition Corp. Class A Common Stock
PTOC
$8.31M 0.01%
861,585
+375,000
+77% +$3.63M
EMBK
2268
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$8.31M 0.01%
41,862
+36,613
+698% +$7.26M
TACA
2269
DELISTED
Trepont Acquisition Corp I
TACA
$8.31M 0.01%
833,132
AOSL icon
2270
Alpha and Omega Semiconductor
AOSL
$794M
$8.29M 0.01%
264,155
+50,850
+24% +$1.41M
SYK icon
2271
Stryker
SYK
$124B
$8.27M 0.01%
31,365
+23,602
+304% +$6.31M
BGRY
2272
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$8.27M 0.01%
1,176,305
-450,061
-28% -$3.85M
PBF icon
2273
PBF Energy
PBF
$8.13B
$8.27M 0.01%
+637,349
New +$6.61M
PRLB icon
2274
Protolabs
PRLB
$1.92B
$8.27M 0.01%
124,092
+84,697
+215% +$6.62M
RCL icon
2275
CALL
Royal Caribbean
RCL
$76.2B
$8.26M 0.01%
+92,900
New +$7.51M

Similar funds

Israel Englander's Q3 2021 Portfolio in Review

As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

  • Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
  • Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.